Sociodemographic Disparities in the GDMT Usage

JACC Heart Fail. 2023 Feb;11(2):173-175. doi: 10.1016/j.jchf.2022.11.020.

Authors

Purvi Parwani¹, Clyde W Yancy²

Affiliations

¹ Division of Cardiology, Department of Medicine, Loma Linda University Health, Loma Linda, California, USA. Electronic address: [email protected].
² Department of Internal Medicine, Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.

PMID: 36754527
DOI: 10.1016/j.jchf.2022.11.020

No abstract available

Keywords: GDMT; HFrEF; ethnicity; race.

Publication types

Editorial
Comment

MeSH terms

Angiotensin-Converting Enzyme Inhibitors
Cardiovascular Agents* / therapeutic use
Heart Failure* / drug therapy
Humans
Stroke Volume

Substances

Cardiovascular Agents
Angiotensin-Converting Enzyme Inhibitors